Article

In a new study published in Radiology, BCRF investigator Dr. Connie Lehman, founder of Clairity Breast and professor of radiology at …

AI is beginning to narrow a critical gap in breast cancer care. In February, Beth Israel Deaconess Medical Center (BIDMC) became the …

New guidelines from the National Comprehensive Cancer Network® champion artificial intelligence in breast cancer screening

Until now, understanding breast cancer risk outside of family history and BRCA mutations has been challenging. Innovations in AI …

Boston AI startup Clairity is providing assessments of the chance of getting breast cancer for patients at a clinic of Beth Israel …

Beth Israel Deaconess Medical Center (BIDMC) in Boston has administered its first clinical cancer risk score using Clairity Breast, a …

Beth Israel Deaconess Medical Center on Friday rolled out an AI-driven technology that detects the risk of developing breast cancer in …

New tech wants to graduate from detecting existing cancers to predicting future risk.

For the first time, they will receive risk scores revealing their likelihood of developing the disease in the next five years, not based …

Routine mammograms are the mainstay of breast cancer screening. But, with a new type of analysis powered by artificial intelligence, …